Okay, let's tackle this question. The patient is a 4-year-old male with mental retardation, self-mutilation, and hyperuricemia. The question is about an enzyme deficiency involved in a specific metabolic pathway.

First, I need to recall the conditions that present with these symptoms. Mental retardation and self-mutilation are classic signs of Lesch-Nyhan syndrome. Hyperuricemia is also a key feature here. Lesch-Nyhan is caused by a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT). This enzyme is part of the purine salvage pathway. When HGPRT is deficient, purines can't be recycled efficiently, leading to overproduction of uric acid.

Now, looking at the answer choices (even though they're not listed), the correct enzyme would be HGPRT. Let me think about the other options that might be present. Maybe other enzymes in purine metabolism like PRPP synthetase, or perhaps enzymes in the urea cycle? But the key here is hyperuricemia and the neurological symptoms. Lesch-Nyhan is the classic one for HGPRT deficiency.

Wait, another condition is Kelley-Seegmiller syndrome, which is a partial deficiency of HGPRT. But Lesch-Nyhan is more severe. So the answer is definitely HGPRT. The question is about which pathway the enzyme is involved in. The purine salvage pathway is correct. The options might have other pathways like pyrimidine synthesis, urea cycle, etc. So the enzyme is involved in the purine salvage pathway. Therefore, the correct answer is the enzyme involved in the purine salvage pathway.

**Core Concept**
This question tests knowledge of inborn errors of purine metabolism, specifically Lesch-Nyhan syndrome. The condition is caused by *hypoxanthine-guanine phosphoribosyltransferase (HGPRT)* deficiency, which disrupts the purine salvage pathway, leading to uric acid overproduction and neurobehavioral symptoms.

**Why the Correct Answer is Right**
HGPRT deficiency blocks the conversion of hypoxanthine and guanine to inosine monophosphate (IMP) and guanosine monophosphate (GMP), respectively. This impairs purine recycling, forcing de novo purine synthesis and excessive uric acid excretion. Neurological manifestations (mental retardation, self-mutilation) arise from purine imbalance and potential uric acid toxicity in developing neurons.

**Why Each Wrong Option is Incorrect**
**Option A:** *Purine de novo synthesis enzymes* (e.g., PRPP synthetase) are not deficient in Lesch-Nyhan; their overactivity may occur secondarily.
**Option B:** *Urea cycle enzymes* deficiencies cause hyperammonemia, not hyperuricemia.
**Option C:** *Pyrimidine metabolism enzymes* (e.g., OMP decarboxylase) are linked to orotic aciduria, not this triad.
**Option D:** *Xanthine oxidase* deficiency causes xanthinuria, not hyperuricemia.

**Clinical Pearl / High-Yield Fact**
Lesch-Nyhan is the **classic "self-mutilating, hyperuricemic" syndrome** due to H

✓ Correct Answer: D. Recycling of guanine and hypoxanthine